University of Pennsylvania researcher Les Shaw, PhD, received a doctor of humane letters, an honorary degree, from his alma mater Le Moyne College in Syracuse, NY, this past weekend.
In his acceptance speech, Dr. Shaw spoke about the Alzheimer’s Disease Neuroimaging Initiative (ADNI) and the importance of diversity in research.
“I’m very happy to say, in the spirit of the Ignatian principle of service to others, that a hallmark part of that study now is to address underserved minorities,” Dr. Shaw said.
Dr. Shaw is a professor of pathology and laboratory medicine. He has been a pioneer in therapeutic drug monitoring, establishing the toxicology and therapeutic drug monitoring laboratory at the University of Pennsylvania (serving as director since 1977), and participated in several international consensus panels devoted to defining best practices.